Diabetes and Endocrinology, London 2014

Friday 12 December 2014

This one day Masterclass covers all the essential updates, new guidelines and best practice in the management of key diabetes and endocrinology conditions in secondary care. Update your knowledge with our six expert speakers and improve your practice instantly with our interactive sessions and quality take home messages.

Course approved for 6 CPD credits by the Royal Colleges of Physicians

This event has already taken place

Course Details

Date: Friday 12 December 2014

Start Time: 9am

End Time: 5pm

Audience: Physicians, consultants and trainees, junior doctors, GPs with specialty interests

Location: BMA House, London WC1H 9JR

Map of BMA House, London WC1H 9JR

Course Benefits:

Track Your Learning guides

6 month subscription to BMJ Best Practice

CPD certificate of attendance

Comprehensive digital course handbook

Approved by the Federation of the Royal College of Physicians for 6 category 1 (external) CPD credit(s).
Individual participants should only record the number of hours they attend

Counts towards your Revalidation

8am - 9am Registration and Refreshments
9am - 9.10am Welcome and Introduction by the Chair, Dr Tahseen Chowdhury
9.10am - 10.00am

New treatments for diabetes with Professor Steven Gough

• Individualising glucose targets and therapy
• Update on controversies in GLP-1 and DPP-4 therapy
• Where do SGLT-2 inhibitors fit in?
• New drugs / combinations on the horizon?

10.00am - 10.45am

Current concepts in the prevention and management of diabetic foot disease with Dr Gerry Rayman

• Diabetic foot disease – the scale of the problem
• Simple screening methods for high risk feet
• Prevention of foot ulceration
• Management of diabetic foot problems in hospital illustrated by case studies

10.45am - 11.05am Refreshments
11.05am -11.50am

Monogenic Diabetes with Professor Graham Hitman

• How common is monogenic diabetes?
• How should we identify people?
• Does treatment change if monogenic diabetes is identified?
• Case studies

11.50am - 12.30pm

Managing the complexities of diabetes and renal disease with Dr Peter Winocour

• Managing diabetic patients with CKD
• Diabetes patients on dialysis
• Case studies

12.30pm - 1.30pm Lunch
1.30pm - 2.15pm

Sponsored symposium supported by Eli Lilly and Company  Lilly

Back to the future – insulin therapy in the 21st century with  Professor David Russell-Jones

For information on how BMJ Masterclasses work with sponsors please see our sponsorship guidelines.

2.15pm - 3.00pm

An update on the prevention and management of osteoporosis with Professor Ali Jawad

• Screening for osteoporosis
• Prevention of osteoporosis
• Management strategies for individuals with osteoporosis illustrated by case studies

3.00pm - 3.20pm Refreshments
3.20pm - 4.05pm

Endocrine hypertension with Dr Mona Waterhouse

• How common are endocrine causes of hypertension
• Who to consider for endocrine hypertension
• Screening
• Case studies

4.05pm - 4.50pm

Common calcium and sodium conundrums in clinical practice with Professor Will Drake

• Hyper- and hypocalcaemia
• Hyper- and hyponatraemia
• Case studies

4.50pm - 4.55pm Summary and closing remarks

 Programme subject to change

Dr Tahseen Chowdhury

Consultant Physician and Diabetologist, Barts Health NHS Trust

Tahseen Chowdhury is a diabetes clinician in the department of diabetes and metabolism at the Royal London Hospital, in the East End of London. He runs a large specialist diabetes and metabolism unit, dealing with diabetes particularly among the Bangladeshi community of Tower Hamlets. Dr Chowdhury has a research and clinical interest in diabetes in South Asians, and has authored over 150 publications, including books entitled Diabetes in South Asian people: Explained and Diabetes Management in Clinical Practice. He qualified from the University of Birmingham and trained in Birmingham and Manchester, before becoming a consultant physician in 2000.

Recent publications:

Gouveia CF, Chowdhury TA. Managing hyperglycaemic emergencies: an illustrative case and review of recent British guidelines. Clinical Med 2013;13:160-2

Chowdhury TA, Finer N. Preventing diabetes: a call for concerted national action. Clinical Med 2013; 13:328-9

Hull, SA, Chowdhury TA, Mathur R, Robson J. Improving outcomes for Type 2 diabetic patients by supporting general practice networks: a quality improvement project in East London. BMJ Qual and Saf 2013 Sep 3. doi: 10.1136/bmjqs-2013-002008. 

Declaration of interests: None

Professor Ali Jawad

Consultant rheumatologist, The Royal London Hospital/WHRI QMUL

Professor Ali S M Jawad, MSc (Medical Immunology), FRCP (Lon, Ed, G) DCH, DMedRehab, is a Consultant Rheumatologist at Barts Health NHS Trust and Clinical Professor of Rheumatology at the William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London Since 2008, he has been Associate International Director (Middle East and North Africa) at RCP, International Development Lead at Barts Health and International Co-Chair at The British Society for Rheumatology. He has published widely: 3 books, chapters in several books and more than 120 articles in learned journals. He has won several grants, runs a metabolic bone service and is currently researching the role of RANK ligand in patients with RA and osteoporosis.

Recent publications:

Mohammed M. Albogami, Ali S. Jawad, Rizgar A. Mageed . Bone loss in osteoporosis and arthritis. Pathogenesis and therapeutic strategies. Saudi Medical Journal2014; 35(3) 

Declaration of interests: None

Dr Peter Winocour

Consultant Diabetologist and Clinical Director, East and North Herts NHS Trust

Peter Winocour is a consultant physician to the East and North Hertfordshire NHS Trust appointed in 1993. He has served as the Clinical Director for Diabetes and Endocrine services since 2008. He qualified in 1979 and received his M.D. degree from the University of Glasgow, and undertook further training in Manchester and Newcastle. Dr Wincour is a past Chairman of the Association of British Clinical Diabetologists and has coordinated national surveys of specialist diabetes services, and reported on the practical issues of meeting targets in the routine diabetes care, casting doubt on national and international guidelines. Dr. Winocour’s research interest in diabetes and endocrinology has resulted in publication of over 80 original articles . Currently he is coordinating joint ABCD-Renal Association guidelines on diabetic nephropathy. Dr Winocour was the Diabetes lead in the published JBS3 guidelines on CVD prevention. He is currently RCPL Secretary of the Joint Speciality Committee in Diabetes and Endocrinology and ABCD Lead on Transitional Diabetes Care.

Recent publications:

Winocour PH . Care of adolescents and young adults with diabetes - much more than transitional care : a personal view . Clinical Medicine 2014:14:3 : 274-278 

Declaration of interests: I have served on several pharmaceutical industry advisory boards including Jannsen , Astra Zeneca , BMS , Novo Nordisk , MSD and Takeda

Dr Gerry Rayman

Consultant Diabetologist, The Diabetes Centre, Ipswich Hospital

Dr Gerry Rayman is Head of Service at the Diabetes and Endocrine Centre, Ipswich Hospital. He has been NHSDiabetes’ clinical lead for the diabetic foot and national lead on inpatient diabetes care. He is the specialist medical advisor to DiabetesUK and clinical lead for their ‘Putting Feet First campaign’. He is the current President of the Endocrine and Diabetes section of the Royal Society of Medicine
Dr Rayman contributed to development of the National Diabetes Foot Audit, NCEPOD on amputations, and two NICE guidelines on the diabetic foot (CG10 and CG119).
Dr Rayman has been involved in organising conferences for DiabetesUK and the RSM and co-leads the Malvern international foot conference. He lectures nationally and internationally on the diabetic foot.

Recent publications:

Cost of diabetic foot disease to the National Health Service in England. Kerr M, Rayman G, Jeffcoate WJ. Diabet Med. 2014 Jul 1

New national diabetes footcare audit of England and wales. Jeffcoate W, Holman N, Rayman G, Valabhji J, Young B. Diabet Med. 2014 Sep;31(9):1022-3

The Ipswich Touch Test: a simple and novel method to screen patients with diabetes at home for increased risk of foot ulceration. Sharma S, Kerry C, Atkins H, Rayman G. Diabet Med. 2014 Sep;31(9):1100-3.

Declaration of interests: none

Professor Graham Hitman

Blizard Institute Director and Professor of Molecular Medicine & Diabetes, Queen Mary University of London

Graham Hitman's main research interests are the genomics and the prevention of type 2 diabetes. He is the co-ordinator of an EU funded program, studying the gene environmental interaction in pregnancy and its relation to future cardiometabolic disease in the offspring in South Asian people. He is one of the principal investigators of the CARDS trial that has influenced the development of current lipid lowering guidelines in diabetes. He has over 250 peer-reviewed publications.

Declaration of interests: none

Professor Will Drake

Will Drake trained at the University of Oxford and the Royal London Hospital Medical College. After junior medical jobs in London and in Cape Town, South Africa, he returned to UK to specialise in Endocrinology at St Bartholomew’s Hospital. During his specialist registrar training and a laboratory research fellowship, he developed clinical research interests in the use of pegvisomant in acromegaly; and in the practice of GH replacement, both in adults and in adolescents. Following a 12 month medicine and endocrinology fellowship in Vancouver, Canada, he returned to the UK and now holds the position of Consultant Physician/Professor of Clinical Endocrinology at St Bartholomew’s Hospital.

Professor David Russell-Jones – symposium speaker

Professor of Diabetes & Endocrinology, Royal Surrey County Hospitals NHS Foundation Trust

David Russell-Jones qualified from Guy’s and St Thomas’ Hospital medical school in 1985.  He did his SHO training in the ‘golden circle’ of famous London postgraduate institutions, including the Hammersmith, Brompton and Queens Square, before returning to St Thomas’ as registrar.  He performed an MD under the direction of Professor Peter Sonksen.

He was appointed lecturer at Guy’s and St Thomas’ followed by Senior Lecturer and Consultant Physician in 1994.  In 1998 he was appointed Professor of Diabetes and Endocrinology at the University of Surrey and Consultant Physician at the Royal Surrey County Hospital where he runs a full specialist diabetes and endocrine service for patients, including a large pituitary clinic.  He is a full part of the general medical ‘take’ in addition to running specialist clinics and doing extensive research. He has recently been appointed by NHS England to be a member of the “Clinical Reference Group” for both specialist Endocrinology and specilaist Diabetes.  His department has attracted large research grants and was rated 5*A in the recent university research assessment exercise.

Professor Russell-Jones raised £2 million and built an innovative ambulatory care and research centre, called the cedar centre, for patients with diabetes and endocrine disorders.  He persuaded Sir Nicholas Grimshaw (of the Eden project and Waterloo International fame) to design the centre which was opened by Prince Andrew in 2005.  The cedar centre was then donated to the NHS.


Further speaker biographies, recent publications and declarations will be uploaded in due course